Julie Taguchi, MD
Basic profileJulie Taguchi is an Oncology physician affiliated with Sansum Medical Clinic. OpenAlex indexes 12 publications with 1,105 citations (h-index 5); ClinicalTrials.gov lists 2 registered studies matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Publications indexed by OpenAlex. Counts exclude supporting files.
Citations across these publications.
H-index from these publications.
Clinical & industry
trials, payments and federal fundingClinical trials
- A New Hormone Replacement Paradigm: Physiologic Restoration Study
Sponsor: Women's Hormone Network
- Evaluate the Safety Profile and Ability of TW1025 Oral Solution to Decrease Fatigue
Sponsor: Meriyana Bio Inc.
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
2 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Janssen Biotech, Inc.Program year20251 payment$123
- Janssen Biotech, Inc.Program year20241 payment$125
- Daiichi SankyoProgram year2023126 paymentsResearch$124,951
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Genitourinary & hormones
63.6%Progesterone63.6%Progesterone100%Part D≥13 patientsMetabolism & gastrointestinal
18.2%Biguanide (metformin)18.2%Metformin Hcl100%Part D<11 patientsSensory organs
18.2%Corticosteroid18.2%Hydrocortisone100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Assessing Patient Readiness to Engage in End-of-life Discussions: Development and Pilot Testing of the End-of-Life Readiness Assessment (ERA) Survey (GP719)
Journal of Pain and Symptom Management
2020 - DEVELOPMENT AND PILOT TESTING OF THE END-OF-LIFE READINESS ASSESSMENT (ERA) SURVEY
Innovation in Aging
2019
Similar KOLs
Other experts from the same institution or the same specialty.
Mukul Gupta, MD
Sansum Medical Clinic
Andrew Mester, MD
Sansum Medical Clinic
Gregory Cogert, MD
Sansum Medical Clinic
Scott Tobis, MD
Sansum Medical Clinic
Carl June, MD
University of Pennsylvania
Stuart Orkin, MD
Harvard Medical School
Rainer Storb
University of Washington
Christina Fitzmaurice, MD
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”